HEXO Corp (HEXO)
0.71
0.00 (0.00%)
USD |
NASDAQ |
Jun 30, 16:00
HEXO EPS Diluted (Quarterly): -1.939 for April 30, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2023 | -1.939 |
| January 31, 2023 | 0.1928 |
| October 31, 2022 | -0.9466 |
| July 31, 2022 | 0.4348 |
| April 30, 2022 | -3.755 |
| January 31, 2022 | -21.43 |
| October 31, 2021 | -5.121 |
| July 31, 2021 | -5.810 |
| April 30, 2021 | -1.889 |
| January 31, 2021 | -1.854 |
| October 31, 2020 | -0.4234 |
| July 31, 2020 | -14.38 |
| April 30, 2020 | -2.649 |
| January 31, 2020 | -48.08 |
| October 31, 2019 | -9.728 |
| July 31, 2019 | -8.853 |
| April 30, 2019 | -1.682 |
| January 31, 2019 | -0.8406 |
| Date | Value |
|---|---|
| October 31, 2018 | -3.007 |
| July 31, 2018 | -2.576 |
| April 30, 2018 | -0.4398 |
| January 31, 2018 | -4.427 |
| October 31, 2017 | -1.343 |
| July 31, 2017 | 1.695 |
| April 30, 2017 | -7.157 |
| January 31, 2017 | -5.458 |
| December 31, 2016 | -0.4196 |
| September 30, 2016 | -0.4294 |
| June 30, 2016 | -0.2059 |
| March 31, 2016 | -0.816 |
| December 31, 2015 | -0.1558 |
| September 30, 2015 | -0.428 |
| June 30, 2015 | -0.0438 |
| March 31, 2015 | -0.4523 |
| December 31, 2014 | -2.955 |
| June 30, 2014 | -0.0366 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-48.08
Minimum
Jan 2020
0.4348
Maximum
Jul 2022
-6.935
Average
-2.649
Median
Apr 2020
EPS Diluted (Quarterly) Benchmarks
| Acasti Pharma Inc | -0.54 |
| Aurinia Pharmaceuticals Inc | -0.08 |
| Edesa Biotech Inc | -0.10 |
| Lexaria Bioscience Corp | -0.37 |
| Liminal Biosciences Inc | -2.193 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -86.43M |
| Revenue (Quarterly) | 15.92M |
| Total Expenses (Quarterly) | 35.88M |
| Gross Profit Margin (Quarterly) | -43.34% |
| Profit Margin (Quarterly) | -543.0% |